Clinical Trial Update: Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial results for lenalidomide, rituximab, cyclophosphamide, and dexamethasone in previously untreated low-grade non-Hodgkin lymphoma were reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)
• Revlimid (lenalidomide)
• Rituxan (rituximab)

Snippet

Sponsor: Mayo Clinic | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2016-02-08